<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170806035517N9</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-04-26</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Effects of an 8‑week foot and neuromuscular exercise program on leg movement and forces during landing and running in men after ACL reconstruction with pronated‑footed posture</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effects of an 8‑week combined intrinsic foot muscle strengthening and neuromuscular training program versus usual care on lower extremity kinetics and kinematics during single‑leg landing and running in men with anterior cruciate ligament reconstruction and functional foot pronation: a randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-05-10</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/89634</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: Two-arm parallel randomized controlled trial with pre-test and post-test assessments. Participants are randomly allocated to an intervention group (combined intrinsic foot muscle strengthening and neuromuscular training) or a usual care control group. Outcome assessors are intended to be blinded to group allocation, Randomization description: Randomization was performed at the individual level using a computer-generated simple randomization procedure.
First, a list of eligible participants was prepared. Then, an independent researcher who was not involved in participant recruitment, assessment, or intervention delivery generated the random allocation sequence in Microsoft Excel using the RAND() function. Each participant was assigned a unique code, and codes were randomly allocated in a 1:1 ratio to the intervention group (combined intrinsic foot muscle strengthening and neuromuscular training) or the control group (usual care).
The random sequence was created before the start of recruitment and was transferred to a series of sequentially numbered, opaque, sealed envelopes. For each newly enrolled participant, the next envelope in numerical order was opened by a person not involved in outcome assessment, and the group assignment inside was implemented.
No stratification factors were used (i.e., no stratified randomization).
Allocation concealment was ensured by using the opaque sealed envelopes and by keeping the randomization list inaccessible to the investigators and outcome assessors until the moment of assignment, Blinding description: In this randomized controlled trial, blinding is implemented at the level of outcome assessors and data analysts.
Participants: All participants are fully informed that they are taking part in a randomized controlled trial with two different exercise programs. They provide written informed consent prior to randomization. Participants are not told which program is considered the primary experimental intervention in order to reduce expectation bias, but due to the differences in content and intensity between the exercise protocols, full participant blinding is not feasible.
Care providers: The exercise trainers/physiotherapists who deliver the intervention necessarily know which exercise program they are administering to each participant. Therefore, care providers are not blinded to group allocation.
Investigators: The principal investigator and co-investigators are responsible for protocol development, supervision of recruitment, and safety monitoring, and thus inevitably have access to information about the intervention protocols. Although they are not involved in the day‑to‑day outcome measurements, they cannot be considered fully blinded in all their roles.
Outcome assessors: Outcome assessors who perform biomechanical and functional assessments (e.g. kinematic, kinetic, and performance measurements) are blinded to group allocation. Participants are identified only by a unique study code during assessment sessions, and assessors do not have access to the randomization list or to any information revealing group assignment. Assessment visits are scheduled and coordinated by a study coordinator who is not involved in outcome measurements, to minimize the risk of unblinding.
Data analysts: Data are exported in a coded format, with intervention groups labeled as, for example, “Group A” and “Group B” without indication of which is the experimental or control condition. The statistician/data analyst performs all primary analyses using these anonymized group codes and remains blinded to the actual meaning of group labels until the main analyses are completed and the analysis plan is finalized.
Data and Safety Monitoring Board: No formal Data and Safety Monitoring Board (DSMB) is established for this investigator‑initiated, small‑scale exercise trial. Safety monitoring is performed by the investigators, who are not blinded to the overall study design.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Anterior cruciate ligament (ACL) reconstruction with concomitant functional foot pronation. Condition 2: Men with unilateral anterior cruciate ligament (ACL) reconstruction and concomitant functional foot pronation.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: participants in the intervention group will receive an 8‑week combined exercise program consisting of intrinsic foot muscle strengthening exercises and neuromuscular training in addition to their usual post‑reconstruction care. The training program will be performed 3 sessions per week, on non‑consecutive days, for approximately 60 minutes per session, under the supervision of a trained exercise specialist.Each session will start with a 5 to 10 minute warm‑up including light aerobic activity such as stationary cycling or brisk walking and dynamic stretching of the lower extremity. Then, approximately 15 minutes of intrinsic foot muscle strengthening exercises will be performed, including exercises such as towel curls, short‑foot exercises, toe spreading, and resisted toe flexion and extension using elastic bands, with progressive increases in difficulty based on the participant’s tolerance.After that, approximately 30 minutes of neuromuscular training will be carried out, focusing on dynamic postural control and lower limb alignment. This part will include single‑leg balance exercises on stable and unstable surfaces, step‑downs, squats and lunges with emphasis on proper knee and hip alignment, single‑leg landing and jump‑landing drills from a standardized height, and perturbation or balance exercises as appropriate. Exercise intensity and complexity will be progressed during the 8‑week period according to a predefined progression protocol and the participant’s clinical status and pain response.Each session will end with 5 to 10 minutes of cool‑down including stretching of the lower extremity muscles. Participants will be monitored continuously during the sessions for pain, swelling, or any adverse events, and exercises will be modified or stopped if necessary. Adherence to the program will be recorded for each participant by documenting attendance at all scheduled sessions. Intervention 2: Control group: participants in the control group will receive only their usual post‑operative and rehabilitation care after anterior cruciate ligament reconstruction, according to the routine protocols of their treating orthopedic surgeon and physiotherapist. They will not receive the structured combined exercise program of intrinsic foot muscle strengthening and neuromuscular training that is provided to the intervention group.During the 8‑week study period, participants in the control group will be allowed to continue their usual daily activities and any standard physiotherapy or home exercises that have already been prescribed as part of their routine care, but no additional supervised training sessions will be scheduled by the research team. They will be contacted or visited only for baseline and post‑intervention assessments, similar to the intervention group. Any changes in medication, additional treatments, or new injuries during the study will be recorded.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Deidentified individual participant data (IPD) and supporting study documents
The following items may be shared with qualified researchers upon reasonable request:
– Deidentified individual participant data (IPD) for all enrolled participants, including baseline characteristics, intervention allocation, and all outcome measures related to knee biomechanics, functional performance, pain, and patient-reported outcomes. No directly identifying variables (e.g., name, national ID, phone number, address) will be included.
– The final version of the study protocol and, if applicable, the English translation of the ethics committee–approved protocol.
– The template of the informed consent form used in this trial, with all identifying information removed.
– The analytic code/scripts used for data processing and statistical analysis (e.g., scripts in MATLAB/Python/SPSS/R or other software used in the study).
– A data dictionary describing variable names, definitions, units, coding schemes, and valid ranges for all shared variables.

When:
Deidentified IPD and supporting documents will be made available after the main results of the trial have been published in a peer-reviewed journal.
The anticipated starting time for data availability is within 6 to 12 months after publication of the primary results. Data and documents will remain available for at least 5 years after the date of first publication, or longer if required by journal or funder policies.

To whom:
Deidentified IPD and supporting documents may be shared with independent researchers affiliated with academic or non-profit research institutions who have a scientifically sound proposal that is consistent with the aims of the original trial and with ethical principles.
Requests from researchers working in for-profit or industry settings may also be considered on a case-by-case basis, provided that there is no conflict with participant confidentiality, institutional policies, or relevant legal/ethical requirements.

Conditions:
Data and documents will be shared only for non-commercial, ethically sound research purposes, such as meta-analyses, secondary analyses related to musculoskeletal biomechanics, injury prevention, rehabilitation, or other closely related research questions.
The following criteria will apply:
– The requesting researcher must submit a brief research proposal describing the objectives, methods, planned analyses, and data requirements.
– The proposed use of data must be scientifically justified, must not overlap inappropriately with ongoing analyses by the original investigators, and must be consistent with the informed consent obtained from participants and the ethics committee approval.
– The requesting institution must provide evidence of local ethics approval or waiver for the proposed secondary analysis, if applicable.
– A data use agreement (DUA) must be signed, specifying the conditions for data use, data security, prohibition of re-identification attempts, prohibition of data sharing with third parties, and obligations regarding acknowledgement of the original investigators and citation of the primary publication.
– Data will be shared in a secure format (e.g., encrypted files), and only deidentified variables will be included.
– Any results derived from the shared data must be reported in an aggregated, non-identifiable form.

Where to obtain:
Interested researchers should send their data-sharing requests by email to the principal investigator.

How to obtain:
The process for requesting access to deidentified IPD and supporting documents will involve the following steps:
Initial contact: The interested researcher sends an email to the principal investigator briefly describing the proposed secondary analysis (research question, main methods, and data needed).
Submission of documents: If the proposal is potentially acceptable, the requester will be asked to submit:– A short written proposal (2–5 pages)– A recent curriculum vitae (CV) of the responsible researcher– Evidence of local ethics committee approval or waiver (if applicable)
Review of request: The principal investigator (and, if needed, the supervising committee or local ethics committee) will review the request to ensure scientific merit, feasibility, and consistency with the original consent and ethical requirements. This review is expected to take approximately 4 to 8 weeks, depending on the complexity of the request.
Data use agreement: If the request is approved, a data use agreement (DUA) will be sent to the requester. Data will be shared only after both parties have signed the DUA.
Data transfer: After the DUA is finalized, the deidentified dataset, data dictionary, relevant code/scripts, and agreed supporting documents will be transferred in a secure manner (e.g., encrypted files via secure file transfer or password-protected archive).
The overall time from initial request to data access is expected to be approximately 1 to 3 months, depending on the completeness of the applicant’s documents and the complexity of the proposed analysis.

Comments:
All data sharing will be conducted in accordance with applicable institutional policies, national regulations, and the conditions specified in the ethics committee approval.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amirali Jafarnezhadgero</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University, Hamedan Branch, Professor Mussivand Boulevard, Hamedan, Iran</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6518115743</zip>
        <telephone>+98 81 3449 4042</telephone>
        <email>amiralijafarnezhad@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Amirali Jafarnezhadgero</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University, Hamedan Branch, Professor Mussivand Boulevard, Hamedan, Iran</address>
        <city>Hamedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6518115743</zip>
        <telephone>+98 81 3449 4042</telephone>
        <email>amiralijafarnezhad@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Male participants aged 18 to 40 years.
History of unilateral anterior cruciate ligament reconstruction using hamstring autograft.
Time elapsed since surgery between 12 and 24 months.
Completion of at least 6 months of standard postoperative rehabilitation.
Ability to run and jump without significant pain in the operated limb.
Presence of functional foot pronation based on navicular drop test above the predefined threshold.
No pain, swelling, or functional limitation that prevents participation in the exercise program.
Willingness to participate and signing written informed consent.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>History of previous major surgery or fracture in the lower extremities other than the index ACL reconstruction.
History of other significant ligamentous injuries of the knee (e.g. PCL, MCL, LCL) requiring surgery.
Presence of neurological, neuromuscular, or vestibular disorders affecting balance or gait.
Presence of severe flatfoot or foot deformities requiring orthotic or surgical management.
Current acute musculoskeletal injury or pain in the lower extremities that limits participation.
Systemic diseases such as uncontrolled diabetes, rheumatoid arthritis, or other inflammatory joint diseases.
Participation in other structured lower extremity or neuromuscular training programs during the study period.
Use of assistive devices for ambulation.
Inability to follow instructions or complete the testing protocol.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S83.5</hc_code>
      <hc_code>M21.40</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Sprain of cruciate ligament of knee</hc_keyword>
      <hc_keyword>Flat foot [pes planus] (acquired), unspecified foot</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: participants in the intervention group will receive an 8‑week combined exercise program consisting of intrinsic foot muscle strengthening exercises and neuromuscular training in addition to their usual post‑reconstruction care. The training program will be performed 3 sessions per week, on non‑consecutive days, for approximately 60 minutes per session, under the supervision of a trained exercise specialist.Each session will start with a 5 to 10 minute warm‑up including light aerobic activity such as stationary cycling or brisk walking and dynamic stretching of the lower extremity. Then, approximately 15 minutes of intrinsic foot muscle strengthening exercises will be performed, including exercises such as towel curls, short‑foot exercises, toe spreading, and resisted toe flexion and extension using elastic bands, with progressive increases in difficulty based on the participant’s tolerance.After that, approximately 30 minutes of neuromuscular training will be carried out, focusing on dynamic postural control and lower limb alignment. This part will include single‑leg balance exercises on stable and unstable surfaces, step‑downs, squats and lunges with emphasis on proper knee and hip alignment, single‑leg landing and jump‑landing drills from a standardized height, and perturbation or balance exercises as appropriate. Exercise intensity and complexity will be progressed during the 8‑week period according to a predefined progression protocol and the participant’s clinical status and pain response.Each session will end with 5 to 10 minutes of cool‑down including stretching of the lower extremity muscles. Participants will be monitored continuously during the sessions for pain, swelling, or any adverse events, and exercises will be modified or stopped if necessary. Adherence to the program will be recorded for each participant by documenting attendance at all scheduled sessions.</i_keyword>
      <i_keyword>Control group: participants in the control group will receive only their usual post‑operative and rehabilitation care after anterior cruciate ligament reconstruction, according to the routine protocols of their treating orthopedic surgeon and physiotherapist. They will not receive the structured combined exercise program of intrinsic foot muscle strengthening and neuromuscular training that is provided to the intervention group.During the 8‑week study period, participants in the control group will be allowed to continue their usual daily activities and any standard physiotherapy or home exercises that have already been prescribed as part of their routine care, but no additional supervised training sessions will be scheduled by the research team. They will be contacted or visited only for baseline and post‑intervention assessments, similar to the intervention group. Any changes in medication, additional treatments, or new injuries during the study will be recorded.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Knee flexion angle at initial contact during single-leg landing from a standardized height. Timepoint: Baseline (before starting the intervention) and after 8 weeks of the training program. Method of measurement: Three-dimensional motion analysis will be performed using an optical motion capture system with at least four high-speed cameras (sampling frequency 200 Hertz). Reflective markers will be placed on pelvic and lower extremity anatomical landmarks according to a standard biomechanical model. Knee flexion angle at initial contact during single-leg landing from a standardized height will be calculated using biomechanical modeling software.</prim_outcome>
      <prim_outcome>Maximum vertical ground reaction force during single-leg landing from a standardized height. Timepoint: Baseline (before starting the intervention) and after 8 weeks of the training program. Method of measurement: Ground reaction forces will be recorded using a force platform installed flush with the laboratory floor (sampling frequency 1000 Hertz). Participants will perform single-leg landings from a standardized height onto the center of the force platform. Vertical ground reaction force signals will be filtered using an appropriate low-pass filter, and the maximum vertical ground reaction force during the landing phase will be extracted and normalized to body weight.</prim_outcome>
      <prim_outcome>Peak knee abduction moment during single-leg landing from a standardized height. Timepoint: Baseline (before starting the intervention) and after 8 weeks of the training program. Method of measurement: Three-dimensional inverse dynamics analysis will be used to calculate knee joint moments. Kinematic data of the pelvis and lower extremity will be collected using an optical motion capture system with at least four high-speed cameras (sampling frequency 200 Hertz), and ground reaction forces will be recorded using a force platform (sampling frequency 1000 Hertz). Reflective markers will be placed on anatomical landmarks of the pelvis and lower extremity according to a standard biomechanical model. Using synchronized kinematic and kinetic data, the peak knee abduction moment during the landing phase of single-leg landing from a standardized height will be calculated and normalized to body weight and height.</prim_outcome>
      <prim_outcome>Knee valgus angle at the time of peak vertical ground reaction force during single-leg landing from a standardized height. Timepoint: Baseline (before starting the intervention) and after 8 weeks of the training program. Method of measurement: Three-dimensional motion analysis of the lower extremity will be performed using an optical motion capture system with at least four high-speed cameras (sampling frequency 200 Hertz), synchronized with a force platform (sampling frequency 1000 Hertz). Reflective markers will be placed on anatomical landmarks of the pelvis and lower extremity according to a standard biomechanical model. Knee valgus angle in the frontal plane at the time of peak vertical ground reaction force during single-leg landing from a standardized height will be calculated using biomechanical modeling software.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Performance on the Star Excursion Balance Test to assess dynamic balance and lower limb function. Timepoint: Baseline (before starting the intervention) and after 8 weeks of the training program. Method of measurement: Performance on the Star Excursion Balance Test will be measured by recording the maximum reach distance in eight directions while the participant maintains single-leg stance on the tested limb. The composite score will be calculated by summing the reach distances in all directions and normalizing the total reach distance to the limb length. The test will be performed by trained outcome assessors according to a standardized protocol.</sec_outcome>
      <sec_outcome>Self-reported intensity of knee pain. Timepoint: Baseline (before starting the intervention) and after 8 weeks of the training program. Method of measurement: Knee pain intensity will be assessed using the Numeric Pain Rating Scale, which is an eleven point scale from zero to ten, where zero indicates no pain and ten indicates the worst pain imaginable. Participants will be asked to rate their average knee pain during functional activities over the previous week on this scale.</sec_outcome>
      <sec_outcome>Subjective knee function score based on the International Knee Documentation Committee subjective knee form. Timepoint: Baseline (before starting the intervention) and after 8 weeks of the training program. Method of measurement: Subjective knee function will be assessed using the International Knee Documentation Committee subjective knee form, which is a standardized questionnaire evaluating symptoms, function, and sports activity related to the knee. The responses to all items will be converted to a total score ranging from zero to one hundred, where higher scores indicate better knee function and fewer symptoms. Participants will complete the questionnaire independently, and trained research staff will check the forms for missing responses.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-04-05</approval_date>
        <contact_name>Ethics Committee of Islamic Azad University, Hamedan Branch</contact_name>
        <contact_address>Islamic Azad University, Hamedan Branch, Shahid Mofatteh Boulevard, Hamedan, Iran Hamedan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
